Search Results - "Kaplan, Susan S."

A post hoc analysis utilizing the FDA toxicity grading scale to assess injection site adverse events following immunization with the live attenuated Zoster Vaccine (ZVL) by Popmihajlov, Zoran, Pang, Lei, Brown, Elizabeth, Joshi, Amita, Su, Shu-Chih, Kaplan, Susan S, Willis, English D

“…ZOSTAVAX (ZVL; Zoster Virus Live), is a single dose, live, attenuated vaccine licensed for the prevention of herpes zoster (HZ) and post herpetic neuralgia…”
Get full text

A randomized Phase I/II study to evaluate safety and reactogenicity of a heat-stable rotavirus vaccine in healthy adults followed by evaluation of the safety, reactogenicity, and immunogenicity in infants by Kanchan, Vibhu, Zaman, Khalequ, Aziz, Asma Binte, Zaman, Sheikh Farzana, Zaman, Farzana, Haque, Warda, Khanam, Mahbuba, Karim, Mohammad Mahbubul, Kale, Sachin, Ali, Syed Khalid, Goveia, Michelle G., Kaplan, Susan S., Gill, Davinder, Khan, Wasif Ali, Yunus, Mohammad, Singh, Ajitpal, Clemens, John D.

“…Objectives: To assess the safety and reactogenicity of single oral dose of heat-stable rotavirus vaccine (HSRV) in healthy adults aged 18-45 years followed by…”
Get full text

Postdose 3 G1 serum neutralizing antibody as correlate of protection for pentavalent rotavirus vaccine by Liu, G. Frank, Hille, Darcy, Kaplan, Susan S., Goveia, Michelle G.

“…Although clinical trials of the pentavalent rotavirus vaccine (RotaTeq®, RV5) have demonstrated efficacy against RV gastroenteritis (RGE) in low and…”
Get full text

Safety and antiviral activity of lopinavir/ritonavir-based therapy in human immunodeficiency virus type 1 (HIV-1) infection by Kaplan, Susan S., Hicks, Charles B.

“…Protease inhibitor-based antiretroviral therapy has been shown to decrease the morbidity and mortality associated with human immunodeficiency virus type 1…”
Get full text

Efficacy and safety of a pentavalent live human-bovine reassortant rotavirus vaccine (RV5) in healthy Chinese infants: A randomized, double-blind, placebo-controlled trial by Mo, Zhaojun, Mo, Yi, Li, Mingqiang, Tao, Junhui, Yang, Xu, Kong, Jilian, Wei, Dingkai, Fu, Botao, Liao, Xueyan, Chu, Jianli, Qiu, Yuanzheng, Hille, Darcy A., Nelson, Micki, Kaplan, Susan S.

“…•A randomized, double-blind, placebo-controlled trial was conducted in healthy Chinese infants.•Efficacy and safety of a pentavalent rotavirus vaccine (RV5)…”
Get full text

Heterogeneity of Rotavirus Vaccine Efficacy Among Infants in Developing Countries by Gruber, Joann F, Hille, Darcy A, Liu, G Frank, Kaplan, Susan S, Nelson, Micki, Goveia, Michelle G, Mast, T Christopher

“…BACKGROUND:Rotavirus is the leading cause of severe diarrhea worldwide in young children. Although rotavirus vaccine efficacy is high in developed countries,…”
Get full text

Lopinavir/ritonavir in the treatment of human immunodeficiency virus infection by Kaplan, Susan S, Hicks, Charles B

“…The importance of combination antiretroviral therapy in HIV-infection has been well established. However, many available agents suffer shortcomings that limit…”
Get more information

Immunogenicity of pentavalent rotavirus vaccine in Chinese infants by Mo, Zhaojun, Ma, Xiao, Luo, Peng, Mo, Yi, Kaplan, Susan S., Shou, Qiong, Zheng, Minghuan, Hille, Darcy A., Arnold, Beth A., Liao, Xueyan

“…•RotaTeqTM was immunogenic in Chinese infants.•RotaTeqTM did not interfere with the immune responses to co-administered tOPV in Chinese infants.•RotaTeqTM did…”
Get full text

Inflammation and Immune Activation in Antiretroviral-Treated Human Immunodeficiency Virus Type 1– Infected African Infants and Rotavirus Vaccine Responses by Uprety, Priyanka, Lindsey, Jane C., Levin, Myron J., Rainwater-Lovett, Kaitlin, Ziemniak, Carrie, Bwakura-Dangarembizix, Mutsa, Kaplan, Susan S., Nelson, Micki, Zadzilka, Amanda, Weinberg, Adriana, Persaud, Deborah

“…Biomarkers of inflammation and immune activation were correlated with rotavirus vaccine responses in 68 human immuno-deficiency virus type 1 (HIV-1)–infected…”
Get full text

Safety and immunogenicity of a live attenuated pentavalent rotavirus vaccine in HIV-exposed infants with or without HIV infection in Africa by Levin, Myron J, Lindsey, Jane C, Kaplan, Susan S, Schimana, Werner, Lawrence, Jody, McNeal, Monica M, Bwakura-Dangarembizi, Mutsa, Ogwu, Anthony, Mpabalwani, Evans M, Sato, Paul, Siberry, George, Nelson, Margaret, Hille, Darcy, Weinberg, Geoffrey A, Weinberg, Adriana

“…OBJECTIVE:Although many HIV-infected (HIV+) and HIV-exposed but uninfected (HEU) infants have received live rotavirus vaccines since the WHO recommended…”
Get full text

Safety and immunogenicity of inactivated varicella-zoster virus vaccine in adults with hematologic malignancies receiving treatment with anti-CD20 monoclonal antibodies by Parrino, Janie, McNeil, Shelly A, Lawrence, Steven J, Kimby, Eva, Pagnoni, Marco F, Stek, Jon E, Zhao, Yanli, Chan, Ivan S.F, Kaplan, Susan S

“…Abstract Background Immunocompromised patients can experience significant morbidity and occasional mortality from complications associated with herpes zoster…”
Get full text

Safety, Tolerability and Immunogenicity of Pentavalent Rotavirus Vaccine Manufactured by a Modified Process by Martinón-Torres, Federico, Greenberg, David, Varman, Meera, Killar, John A, Hille, Darcy, Strable, Erica L, Stek, Jon E, Kaplan, Susan S

“…BACKGROUND:Rotavirus is the leading cause of severe diarrhea in infants and young children. The current formulation of pentavalent rotavirus vaccine (RV5) must…”
Get full text

Immunogenicity of Inactivated Varicella Zoster Vaccine in Autologous Hematopoietic Stem Cell Transplant Recipients and Patients With Solid or Hematologic Cancer by Boeckh, Michael J, Arvin, Ann M, Mullane, Kathleen M, Camacho, Luis H, Winston, Drew J, Morrison, Vicki A, Hurtado, Kimberly, Durrand Hall, Jessie, Pang, Lei, Su, Shu-Chih, Kaplan, Susan S, Annunziato, Paula W, Popmihajlov, Zoran

“…Abstract Background In phase 3 trials, inactivated varicella zoster virus (VZV) vaccine (ZVIN) was well tolerated and efficacious against herpes zoster (HZ) in…”
Get full text

Antiretroviral therapy in HIV-infected patients with multidrug-resistant virus: applying the guidelines to practice by Kaplan, Susan S, Mounzer, Karam C

“…Abstract Current treatment guidelines recommend maintenance of HIV-1 viral load below detectable levels (<50 copies per milliliter), even in extensively…”
Get more information

A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Clinical Trial to Study the Safety, Tolerability, Efficacy, and Immunogenicity of Inactivated Vzv Vaccine (ZVIN) in Recipients of Autologous Hematopoietic Cell Transplants (Auto-Hcts) by Winston, Drew J, Mullane, Kathleen M, Boeckh, Michael J, Cornely, Oliver A, Hurtado, Kimberly, Su, Shu-Chih, Pang, Lei, Zhao, Yanli, Chan, Ivan S.F, Stek, Jon E, Kaplan, Susan S, Parrino, Janie, Annunziato, Paula, Popmihajlov, Zoran, Arvin, Ann

Get full text

Longitudinal assessment of immune response and viral characteristics in HIV-infected patients with prolonged CD4(+)/viral load discordance by Kaplan, Susan S, Ferrari, Guido, Wrin, Terri, Hellmann, Nicholas S, Tomaras, Georgia D, Gryszowka, Victoria E, Fiscus, Susan A, Weinhold, Kent J, Hicks, Charles B

“…Although suppression of HIV-1 RNA below the limit of detection is associated with optimal outcomes, many patients can maintain or increase their CD4(+) count…”
Get more information

6 - A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Clinical Trial to Study the Safety, Tolerability, Efficacy, and Immunogenicity of Inactivated Vzv Vaccine (ZVIN) in Recipients of Autologous Hematopoietic Cell Transplants (Auto-Hcts) by Winston, Drew J., Mullane, Kathleen M., Boeckh, Michael J., Cornely, Oliver A., Hurtado, Kimberly, Su, Shu-Chih, Pang, Lei, Zhao, Yanli, Chan, Ivan S.F., Stek, Jon E., Kaplan, Susan S., Parrino, Janie, Annunziato, Paula, Popmihajlov, Zoran, Arvin, Ann

Get full text

A post hoc analysis utilizing the FDA toxicity grading scale to assess injection site adverse events following immunization with the live attenuated Zoster Vaccine (ZVL) by Popmihajlov, Zoran, Pang, Lei, Brown, Elizabeth, Joshi, Amita, Su, Shu-Chih, Kaplan, Susan S., Willis, English D.

“…Background: ZOSTAVAX (ZVL; Zoster Virus Live), is a single dose, live, attenuated vaccine licensed for the prevention of herpes zoster (HZ) and post herpetic…”
Get full text